Advertisement
U.S. markets open in 8 hours 1 minute

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
219.40+0.09 (+0.04%)
At close: 04:00PM EDT
219.41 +0.01 (+0.00%)
After hours: 06:49PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
9,835,600
9,835,600
10,173,400
10,981,700
13,444,600
Cost of Revenue
2,533,400
2,533,400
2,278,300
2,109,700
1,805,200
Gross Profit
7,302,200
7,302,200
7,895,100
8,872,000
11,639,400
Operating Expense
5,471,100
5,471,100
4,993,200
6,064,000
7,193,100
Operating Income
1,831,100
1,831,100
2,901,900
2,808,000
4,446,300
Net Non Operating Interest Income Expense
29,600
29,600
-157,300
-242,600
-180,500
Other Income Expense
-563,900
-563,900
847,200
-820,200
781,700
Pretax Income
1,296,800
1,296,800
3,591,800
1,745,200
5,047,500
Tax Provision
135,300
135,300
632,800
52,500
992,300
Earnings from Equity Interest Net of Tax
0
0
2,600
34,900
5,300
Net Income Common Stockholders
1,161,100
1,161,100
3,046,900
1,556,100
4,000,600
Diluted NI Available to Com Stockholders
1,161,100
1,161,100
3,046,900
1,556,100
4,000,600
Basic EPS
10.14
8.02
20.96
10.44
24.86
Diluted EPS
10.06
7.97
20.87
10.40
24.80
Basic Average Shares
144,475
144,700
145,300
149,100
160,900
Diluted Average Shares
145,475
145,600
146,000
149,600
161,300
Total Operating Income as Reported
-
-
-
2,840,700
4,550,100
Total Expenses
8,004,500
8,004,500
7,271,500
8,173,700
8,998,300
Net Income from Continuing & Discontinued Operation
1,161,100
1,161,100
3,046,900
1,556,100
4,000,600
Normalized Income
1,663,218
1,663,218
2,340,485
2,346,262
3,375,224
Interest Income
276,500
276,500
89,300
11,000
42,000
Interest Expense
246,900
246,900
246,600
253,600
222,500
Net Interest Income
29,600
29,600
-157,300
-242,600
-180,500
EBIT
1,543,700
1,543,700
3,838,400
1,998,800
5,270,000
EBITDA
2,038,500
2,038,500
4,356,800
2,880,100
5,734,800
Reconciled Cost of Revenue
2,279,200
2,279,200
2,125,800
2,503,300
1,812,800
Reconciled Depreciation
494,800
494,800
518,400
487,700
457,200
Net Income from Continuing Operation Net Minority Interest
1,161,100
1,161,100
3,046,900
1,556,100
4,000,600
Total Unusual Items Excluding Goodwill
-560,400
-560,400
857,300
-814,600
778,800
Total Unusual Items
-560,400
-560,400
857,300
-814,600
778,800
Normalized EBITDA
2,598,900
2,598,900
3,499,500
3,694,700
4,956,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-58,282
-58,282
150,885
-24,438
153,424